- Ownership hops held
- 29
An absent edge means not yet observed — never does not exist.
InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. — US company (sec:0001728328). UBO chain traced 29 hops, 7 owners. Every claim linked to its source.
Ownership resolves 29 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- InMed Pharmaceuticals Inc.
None in current sources.
29-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on InMed Pharmaceuticals Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
12 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- ADAR1 CAPITAL MANAGEMENT, LLCAlso holds roles at 4 other companies
- Rallybio Corptenpercentowner
- Keros Therapeutics, Inc.tenpercentowner
- ACASTI PHARMA INC.tenpercentowner
- Cutler Adam D.Also holds roles at 3 other companies
- Mural Oncology plcofficer
- MOLECULAR TEMPLATES, INC.officer
- NAVIDEA BIOPHARMACEUTICALS, INC.director
- GARNER WILLIAM JAlso holds roles at 5 other companies
- TuHURA Biosciences, Inc./NVdirector
- MEGABIOS CORPtenpercentowner
- MEGABIOS CORPdirector
- SCHNEEBERGER DANIELAlso holds roles at 3 other companies
- Rallybio Corptenpercentowner
- Keros Therapeutics, Inc.tenpercentowner
- ANEBULO PHARMACEUTICALS, INC.officer
- Vivo Opportunity Fund Holdings, L.P.Also holds roles at 7 other companies
- SOLENO THERAPEUTICS INC10% owner
- SOLENO THERAPEUTICS INCtenpercentowner
- Terns Pharmaceuticals, Inc.tenpercentowner
- Vivo Opportunity, LLCAlso holds roles at 10 other companies
- SOLENO THERAPEUTICS INC10% owner
- SOLENO THERAPEUTICS INCtenpercentowner
- Terns Pharmaceuticals, Inc.tenpercentowner
12 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns InMed Pharmaceuticals Inc.?
- What is InMed Pharmaceuticals Inc.'s risk level?
- Where does InMed Pharmaceuticals Inc. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for InMed Pharmaceuticals Inc. — nothing is disclosed before that.